ORGANOGENESIS HOLDINGS INC. Cash and Cash Equivalents
ORGANOGENESIS HOLDINGS INC. (ORGO) had Cash and Cash Equivalents of $46.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $46.10M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $91.38M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $93.68M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $63.74M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $46.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $91.38M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $93.68M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $63.74M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $73.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $109.97M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $135.57M 10-K · filed 2026-02-26 |
| 2024-09-30 | $94.34M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $89.90M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $88.63M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $103.84M 10-K · filed 2025-02-27 |
| 2023-09-30 | $98.23M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $88.92M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $88.69M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $102.48M 10-K · filed 2024-02-29 |
| 2022-09-30 | $107.25M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $112.28M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $107.90M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $113.93M 10-K · filed 2023-03-01 |
| 2020-12-31 | $84.39M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |